Drug Profile
SPT 201
Latest Information Update: 12 Mar 2016
Price :
*
At a glance
- Originator Valeant Pharmaceuticals International
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Clinical Phase Unknown Decreased libido
Most Recent Events
- 13 Jan 2016 Clinical trials in Decreased libido in USA (unspecified route) before January 2016